Umbilical cord blood transfusion for preterm neonates: A literature review
Bozhbanbaeva N.S. Tangirbergen S.S. Muzdubaeva U.R.
30 September 2025Kaz Med Print LLP
Reproductive Medicine (Central Asia)
2025#2025Issue 3136 - 142 pp.
Relevance: Premature infants, especially those with low birth weight, often suffer from anemia of prematurity (AOP), a condition that can negatively impact growth and neurodevelopment. Although red blood cell (RBC) transfusions are widely used to treat AOP, they carry significant risks, including infections, immunological reactions, and iron overload. Cord blood (CB) has emerged as a promising alternative, offering a rich source of hematopoietic stem cells, red blood cells, and immunomodulatory factors. This review aimed to examine current views on cord blood transfusion in preterm infants and assess its physiological benefits, logistical and ethical aspects, and clinical outcomes to inform subsequent implementation in the clinical transfusion practice of neonatology departments in Kazakhstan. Methods: A literature search was conducted in PubMed and Google Scholar from 2015 to 2024 using the following keywords: “cord blood”; “preterm infants”; “autologous transfusion” and “allogeneic transfusion”. After a two-stage selection, 26 articles were accepted for analysis and critically appraised by the authors. Results: CB is a safe and compatible transfusion component for preterm infants, with physiological advantages due to its high fetal hemoglobin (HbF) content and regenerative components. CB RBC reduces the risk of severe retinopathy of prematurity and improves oxygen delivery, neurodevelopment, and overall outcomes in preterm infants compared with adult blood transfusions. Conclusion: As an autologous blood source, CB has the advantage of reducing the transfusion-related risks typically associated with allogeneic blood products, making it a potentially safer option for treating anemia of prematurity and enhancing neonatal immune function. As neonatal care continues to advance, PC transfusion may improve survival rates and overall quality of life in preterm infants, potentially redefining transfusion practices for this vulnerable population.
allogeneic transfusion , autologous transfusion , benefits , cord blood transfusion , preterm infants , risks
Text of the article Перейти на текст статьи
Department of Neonatology, Asfendiyarov Kazakn National Medical University, Almaty, Kazakhstan
Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Department of Neonatology
Asfendiyarov Kazakh National Medical University
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026